Human Embryonic Stem Cells Could Safely Treat Eye Diseases, Research Suggests
Monday, June 15, 2009 - 10:14
in Health & Medicine
Advanced Cell Technology and its collaborators at OHSU report the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium produced under manufacturing conditions suitable for human clinical trials. The research shows long-term functional rescue using hESC-derived cells in both the RCS rat and Elov14 mouse, animal models of retinal degeneration and Stargardt disease, respectively.